Pregabalin Sun 150 mg hard capsules EFG

Package leaflet: Information for the user

Introduction

Package leaflet: Information for the patient

Pregabalin SUN 150 mg hard capsules EFG

Read all of this leaflet carefully before you start taking this medicine, because it contains important information for you.

• Keep this leaflet, as you may need to read it again.
• If you have any questions, ask your doctor or pharmacist.
• This medicine has been prescribed for you only, and you should not give it to other people, even if they have the same symptoms as you, because it may harm them.
• If you experience any adverse effects, talk to your doctor or pharmacist, even if they are adverse effects not listed in this leaflet. See section 4.

Contents of the leaflet:

1. What Pregabalin SUN is and what it is used for
2. What you need to know before taking Pregabalin SUN
3. How to take Pregabalin SUN
4. Possible side effects
5. How to store Pregabalin SUN
6. Contents of the pack and other information

1. What is Pregabalina SUN and what is it used for

Pregabalina SUN belongs to a group of medicines used to treat epilepsy, neuropathic pain, and generalized anxiety disorder (GAD) in adults.

Peripheral and central neuropathic pain: Pregabalina SUN is used to treat chronic pain caused by nerve damage. Various diseases can cause peripheral neuropathic pain, such as diabetes or herpes. The pain sensation may be described as warmth, burning, throbbing, shooting, stabbing, sharp pain, spasms, continuous pain, tingling, numbness, and prickling sensations. Peripheral and central neuropathic pain may also be associated with mood changes, sleep disturbances, fatigue (tiredness), and may affect physical and social activities and overall quality of life.

Epilepsy: Pregabalina SUN is used in the treatment of certain types of epilepsy (partial seizures with or without secondary generalization) in adults. Your doctor will prescribe pregabalin if your current treatment does not adequately control your condition. You should take Pregabalina SUN as an add-on to your current treatment. Pregabalina SUN must not be used as monotherapy; it should always be used in combination with other antiepileptic treatments.

Generalized anxiety disorder: Pregabalina SUN is used in the treatment of generalized anxiety disorder (GAD). Symptoms of GAD include excessive and prolonged anxiety and worry that are difficult to control. GAD may also cause restlessness or a feeling of being keyed up or on edge, easy fatigue, difficulty concentrating or mind going blank, irritability, muscle tension, or sleep disturbance. This is different from the stress and worries of everyday life.

2. What you need to know before taking Pregabalin SUN

Do not take Pregabalin SUN

If you are allergic to pregabalin or to any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions

Talk to your doctor or pharmacist before taking Pregabalin SUN

• Some patients treated with pregabalin have reported symptoms indicating an allergic reaction. These symptoms include swelling of the face, lips, tongue, and throat, as well as development of widespread skin rash. If you experience any of these symptoms, you must seek immediate medical attention.
• Serious skin reactions, such as Stevens-Johnson syndrome and toxic epidermal necrolysis, have been reported in association with pregabalin treatment. Stop taking pregabalin and seek immediate medical help if you notice any symptoms related to these serious skin reactions described in section 4.
• Pregabalin has been associated with dizziness and somnolence, which may increase the risk of accidental injury (falls) in elderly patients. Therefore, you should exercise caution until you become familiar with the effects this medicine may have on you.
• Pregabalin may cause blurred vision, vision loss, or other changes in eyesight, many of which are transient. If you experience any visual disturbances, you must inform your doctor immediately.
• Diabetic patients who gain weight while taking pregabalin may require adjustments in their diabetes medications.
• Certain adverse effects, such as somnolence, may be more frequent in patients with spinal cord injury, as they may be taking other medications for conditions such as pain or spasticity (stiff or rigid muscles), which have adverse effects similar to those of pregabalin; thus, the intensity of these effects may increase when taken concomitantly.
• Cases of heart failure have been reported in some patients treated with pregabalin. Most of these patients were elderly with cardiovascular disease. Before using this medicine, you must inform your doctor if you have a history of heart disease.
• Cases of kidney problems (renal failure) have been reported in some patients treated with this medicine. If during treatment with pregabalin you notice a decrease in your ability to urinate, inform your doctor, as discontinuation of treatment may improve this condition.
• Some patients taking antiepileptic medicines such as pregabalin have had thoughts of harming themselves or of suicide, or have exhibited suicidal behavior. If at any time you experience such thoughts or behaviors, contact your doctor as soon as possible.
• When pregabalin is taken together with other medicines that may cause constipation (such as certain types of pain medications), gastrointestinal problems (e.g., constipation, intestinal blockage, or intestinal paralysis) may occur. Inform your doctor if you experience constipation, especially if you are prone to this problem.
• Before taking this medicine, inform your doctor if you have a history of alcoholism or of abuse or dependence on medicines or illegal drugs, as this may indicate a higher risk of becoming dependent on pregabalin.
• Cases of seizures have been reported during treatment with pregabalin or shortly after discontinuation of treatment with this medicine. If you experience seizures, contact your doctor immediately.
• Cases of reduced brain function (encephalopathy) have been reported in some patients taking pregabalin who also had other underlying diseases. Inform your doctor if you have a history of serious illness, including liver or kidney disease.
• Cases of breathing difficulties have been reported. If you have disorders of the nervous system, respiratory disorders, renal impairment, or are over 65 years of age, your doctor may prescribe a different dose. Contact your doctor if you experience difficulty breathing or shallow breathing.

Dependence

Some people may become dependent on pregabalin (a need to keep taking this medicine). They may experience withdrawal effects when they stop taking pregabalin (see section 3 “How to take Pregabalina SUN” and “If you stop taking Pregabalina SUN”).

If you are concerned about possibly becoming dependent on pregabalin, it is important that you consult your doctor.

If you notice any of the following symptoms while taking Pregabalina SUN, it could indicate that you have become dependent:

• You need to take this medicine for longer than prescribed by your doctor
• You feel the need to take higher doses than recommended
• You use this medicine for reasons other than those prescribed
• You have made repeated unsuccessful attempts to stop or control use of this medicine
• You feel unwell when you stop taking this medicine, and feel better when you take it again

If you experience any of these symptoms, speak with your doctor to discuss the best treatment approach for you, including when it may be appropriate to stop taking this medicine and how to do so safely.

Children and adolescents

The safety and efficacy of pregabalin have not been established in children and adolescents (under 18 years of age), therefore pregabalin should not be used in this age group.

Taking Pregabalina SUN with other medicines

Inform your doctor or pharmacist if you are taking, have recently taken, or might need to take any other medicines.

Pregabalin and certain medicines may affect each other (interactions). When pregabalin is used together with certain medicines that have a sedative effect (including opioids), these effects may be enhanced, potentially leading to respiratory failure, coma, and death. The degree of dizziness, drowsiness, and reduced concentration may increase if pregabalin is taken together with other medicines containing:

Oxycodone – (used as an analgesic)
Lorazepam – (used to treat anxiety)
Alcohol

Pregabalina SUN can be taken with oral contraceptives.

Taking Pregabalina SUN with food, drinks, and alcohol

Pregabalina SUN capsules can be taken with or without food.

Alcohol consumption is not recommended during treatment with pregabalin.

Pregnancy, breastfeeding, and fertility

You should not take pregabalin during pregnancy or while breastfeeding, unless your doctor has specifically instructed you to do so.

The use of pregabalin during the first 3 months of pregnancy may cause congenital malformations in the fetus requiring medical treatment. In a study reviewing data from women in Nordic countries who took pregabalin during the first 3 months of pregnancy, 6 out of 100 babies had such congenital malformations. This compares with 4 out of 100 babies born to women not treated with pregabalin in the study. Malformations reported include facial clefts, eyes, the nervous system (including the brain), kidneys, and genitals.

An effective method of contraception should be used in women of childbearing potential. If you are pregnant or breastfeeding, think you might be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.

Driving and using machines

Pregabalin may cause dizziness, drowsiness, and reduced concentration. You should not drive, operate heavy machinery, or engage in other potentially hazardous activities until you know whether this medicine affects your ability to perform such tasks.

Pregabalina SUN contains sodium and mannitol

This medicine contains less than 1 mmol of sodium (23 mg) per hard capsule; hence, it is essentially “sodium-free”.

Mannitol may have a mild laxative effect.

3. How to take Pregabalina SUN

Follow exactly the administration instructions for this medicine as given by your doctor. If in doubt, consult your doctor or pharmacist again. Do not take a higher dose than prescribed.

Your doctor will determine the appropriate dose for you.

Pregabalina is for oral use only.

Peripheral and central neuropathic pain, epilepsy, or generalized anxiety disorder:

• Take the number of capsules indicated by your doctor.
• The dose, adjusted according to your condition, is generally between 150 mg and 600 mg daily.
• Your doctor will instruct you to take pregabalin two or three times a day. If twice daily, take pregabalin once in the morning and once at night, approximately at the same time each day. If three times daily, take pregabalin in the morning, at midday, and at night, approximately at the same time every day.

If you feel that the effect of this medicine is too strong or too weak, inform your doctor or pharmacist.

If you are an elderly patient (over 65 years of age), you should take pregabalin as usual, unless you have kidney problems.

Your doctor may prescribe a different dosing regimen and/or different doses if you have kidney problems.

Swallow the capsule whole with water.

Continue taking pregabalin until your doctor tells you to stop.

If you take more Pregabalina SUN than you should

In case of overdose or accidental ingestion, contact your doctor or pharmacist immediately or call the Toxicology Information Service at: 91 562 04 20, indicating the medicine and the amount ingested.

As a result of taking more pregabalin than prescribed, you may feel drowsy, confused, agitated, or restless. Seizures and loss of consciousness (coma) have also been reported.

If you forget to take Pregabalina SUN

It is important that you take pregabalin capsules regularly at the same time each day. If you forget to take a dose, take it as soon as you remember, unless it is almost time for the next dose. In that case, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a forgotten dose.

If you stop taking Pregabalina SUN

Do not stop taking pregabalin suddenly. If you wish to discontinue pregabalin, discuss it with your doctor first. Your doctor will advise you on how to do so. If treatment is to be discontinued, it should be done gradually over a minimum period of one week.

After both short- and long-term treatment with pregabalin, you should be aware that you may experience certain adverse effects known as withdrawal symptoms. These symptoms include sleep disturbances, headache, nausea, anxiety, diarrhea, flu-like symptoms, seizures, restlessness, depression, thoughts of self-harm or suicide, pain, sweating, and dizziness. These symptoms may occur more frequently or severely if you have been taking this medicine for a longer period of time. If you experience withdrawal symptoms, contact your doctor.

If you have any further questions about the use of this medicine, ask your doctor or pharmacist.

4. Possible adverse effects

Like all medicines, this medicine can cause adverse effects, although not everyone will experience them.

Serious adverse effects:

If you experience any of the following adverse effects, stop treatment with Pregabalin SUN and contact your doctor or go to the nearest hospital, as you may require urgent medical attention.

• Hypersensitivity (uncommon, may affect up to 1 in 100 people) and allergic reactions (which may include swelling of the face, swelling of the tongue, difficulty breathing, itching) (rare, may affect up to 1 in 1,000 people).

• Severe skin reaction characterized by flat red patches, or circular or coin-shaped patches on the chest, often with central blisters, peeling of the skin, mouth ulcers, sores in the throat, nose, genitals, and eyes. These serious skin rashes may be preceded by fever and flu-like symptoms (Stevens-Johnson syndrome, toxic epidermal necrolysis). (rare, may affect up to 1 in 1,000 people).

If you experience swelling of the face or tongue, or if your skin becomes red and develops blisters or peels, you must seek immediate medical attention.

• Inflammation of the pancreas (including symptoms such as severe stomach pain, often with nausea and vomiting) (rare, may affect up to 1 in 1,000 people).

Other adverse effects:

Very common (may affect more than 1 in 10 people)

• Dizziness, somnolence, headache

Common (may affect up to 1 in 10 people)

• Increased appetite
• Feeling of euphoria, confusion, disorientation, decreased libido, irritability
• Attention disturbance, lack of coordination, memory impairment, memory loss, tremor, speech difficulty, tingling sensation, numbness, sedation, lethargy, insomnia, fatigue, abnormal sensation
• Blurred vision, double vision
• Dizziness, balance problems, falls
• Dry mouth, constipation, vomiting, flatulence, diarrhea, nausea, bloated abdomen
• Erectile dysfunction
• Swelling of the body including limbs
• Feeling of drunkenness, gait disturbances
• Weight gain
• Sore throat
• Muscle cramp, joint pain, back pain, limb pain, neck muscle spasm
• Sore throat

Uncommon (may affect up to 1 in 100 people)

• Loss of appetite, weight loss, low blood sugar levels, high blood sugar levels
• Altered self-perception, restlessness, depression, agitation, mood changes, difficulty finding words, hallucinations, strange dreams, panic attacks, apathy, aggression, elevated mood, mental deterioration, difficulty thinking, increased libido, sexual problems including inability to reach climax, delayed ejaculation
• Vision changes, unusual eye movements, visual disturbances including tunnel vision, light flashes, spastic movements – abnormal and uncontrollable movements of limbs, decreased reflexes, hyperactivity, dizziness upon standing, skin sensitivity, loss of taste, burning sensation, tremor during movement, decreased consciousness, loss of consciousness, fainting, increased sensitivity to noise, general malaise
• Dry eyes, eye swelling, eye pain, tired eyes, watery eyes, eye irritation
• Heart rhythm disturbances, increased heart rate, low blood pressure, high blood pressure, heart failure
• Flushing, hot flushes
• Difficulty breathing, dry nose, nasal congestion
• Cough, facial swelling, urticaria, itching, runny nose, nosebleeds, snoring
• Increased saliva production, burning sensation, numbness around the mouth
• Sweating, rash, chills, fever
• Cold sensation in hands and feet
• Muscle spasms, joint swelling, muscle stiffness, pain including muscle pain, neck pain
• Difficulty or pain when urinating, inability to control urine
• Weakness, thirst, chest tightness
• Breast pain
• Painful menstrual periods
• Generalized swelling
• Changes in blood and liver test results (elevated blood creatine phosphokinase, elevated alanine aminotransferase, elevated aspartate aminotransferase, decreased platelet count, decreased blood potassium, increased blood creatinine, neutropenia)

Rare (may affect up to 1 in 1,000 people)

• Changes in heartbeat
• Altered sense of smell, oscillating vision, altered depth perception, visual brightness, vision loss
• Dilated pupils, strabismus
• Eye inflammation (keratitis)
• Cold sweat, throat tightness, tongue swelling
• Difficulty swallowing
• Slow or reduced body movement
• Difficulty writing properly
• Fluid in the lungs
• Seizures
• Changes in electrocardiogram (ECG) corresponding to heart rhythm disturbances
• Increased fluid in the abdominal area
• Muscle damage
• Milk secretion, abnormal breast growth, breast enlargement in men
• Interruption of menstrual period
• Kidney problems, reduced urine output, urine retention
• Decreased white blood cell count
• Inappropriate behavior, suicidal behavior, suicidal thoughts
• Jaundice (yellowing of the skin and eyes)
• Parkinsonism, symptoms resembling Parkinson's disease, such as tremor, bradykinesia (reduced ability to move), and muscle rigidity.

Very rare: may affect up to 1 in 10,000 people

• Liver failure.
• Hepatitis (inflammation of the liver).

Not known: frequency cannot be estimated from available data

• Becoming dependent on pregabalin (“drug dependence”).

After stopping short-term or long-term treatment with Pregabalin SUN, you should be aware that you may experience certain adverse effects known as withdrawal symptoms (see “If you stop taking Pregabalin SUN”).

Certain adverse effects, such as somnolence, may be more frequent because patients with spinal cord injury may be taking other medicines to treat, for example, pain or spasticity (tight or stiff muscles), which have adverse effects similar to those of pregabalin, so the intensity of these effects may increase when taken together.

The following adverse reaction has been reported during post-marketing experience: difficulty breathing, shallow breathing.

Reporting of adverse effects

If you experience any adverse effect, consult your doctor or pharmacist, even if they are effects not listed in this leaflet. You may also report them directly through the Spanish Pharmacovigilance System for Human Medicinal Products: https://www.notificaram.es . By reporting adverse effects, you can help provide more information on the safety of this medicine.

5. Storage of Pregabalin SUN

Keep this medicine out of sight and reach of children.

Do not use this medicine after the expiry date stated on the packaging after "EXP". The expiry date refers to the last day of the month indicated.

No special storage conditions are required.

Bottle: after opening, the capsules should be used within 30 days.

Medicines must not be disposed of via wastewater or household waste. Dispose of empty containers and unused medicines at the SIGRE collection point in your pharmacy. If in doubt, ask your pharmacist how to dispose of containers and medicines you no longer need. This will help protect the environment.

6. Package contents and other information

Composition of Pregabaline SUN

The active substance is pregabalin. Each hard capsule contains 150 mg of pregabalin.

The other components are:

Capsule contents:

Mannitol, talc

Capsule composition:

Gelatin, titanium dioxide (E171), purified water, sodium lauryl sulfate

Printing ink:

Shellac, propylene glycol, black iron oxide (E172), potassium hydroxide

Nature of the product and package contents

Pregabaline SUN 150 mg hard capsules:

Size “2” hard gelatin capsules with an opaque white cap and an opaque white body, marked with “rbx” in black ink on the cap and “PG150” on the body, containing white or almost white powder. The length of the capsule is approximately 17.0 – 18.2 mm.

OPA/Al/PVC/Al blister packs:

Pack sizes: 14, 21, 56, 84, 98, 100 or 112 hard capsules

PVC/Aluminum blister packs:

Pack sizes: 14, 21, 28, 56, 84, 98, 100 or 112 hard capsules

HDPE bottle with child-resistant closure:

Pack sizes: 14, 21, 30, 56, 84, 98, 100 or 112 hard capsules

HDPE bottle with screw cap:

Pack size: 500 hard capsules

Only some pack sizes may be commercially available.

Marketing Authorization Holder and Manufacturer

Marketing Authorization Holder:

Sun Pharmaceutical Industries Europe B.V.,

Polarisavenue 87,

2132JH Hoofddorp, The Netherlands

Manufacturer:

Terapia, S.A.

124, Fabricii Street

400 632 – Cluj Napoca

Romania

or

Sun Pharmaceutical Industries Europe B.V.

Polarisavenue 87

2132JH Hoofddorp

The Netherlands

Local representative

Sun Pharma Laboratorios, S.L.

Rambla de Catalunya 53-55

08007 - Barcelona

Spain

+34 93 342 78 90

This medicinal product is authorized in the Member States of the European Economic Area and in the United Kingdom (Northern Ireland) under the following names:

France: PREGABALINE CRISTERS PHARMA 150 mg, gélule

Germany: PREGABALIN BASICS 150 mg Hartkapseln

The Netherlands: Pregabaline SUN 150 mg, harde capsules

Poland: Tabagine

Romania: Pregabalina Terapia 150 mg capsule

United Kingdom (Northern Ireland): Pregabalin Sun 150 mg Capsules, Hard

Date of the most recent review of this leaflet: January 2024

Detailed and up-to-date information on this medicinal product is available on the website of the Spanish Agency of Medicines and Health Products (AEMPS) http://www.aemps.gob.es/